AUR107

Aurigene Discovery Technologies Limited · Phase 1 active Small molecule

At a glance

Generic name	AUR107
Sponsor	Aurigene Discovery Technologies Limited
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

AUR107 CI brief — competitive landscape report
AUR107 updates RSS · CI watch RSS
Aurigene Discovery Technologies Limited portfolio CI